Physician Leader| Cutaneous Oncology Enterprise Leader | Duarte, CA

Physician Leader| Cutaneous Oncology Enterprise Leader | Duarte, CA - (10028001)

Description

Our vision at City of Hope is to create a world-class Cutaneous Oncology Program that brings together clinicians, clinician scientists and and laboratory researchers across the institution to gain a better understanding of cutaneous oncology and to develop better treatments, screening methods, prevention strategies and survivorship care for them.

Our outpatient facility located on our Duarte, CA campus serves as a central hub for patients to have access to the full range of health care professionals, including not only physician specialists, but nurses, genetic counselors, schedulers, social workers, financial counselors, supportive care staff and other health specialists. In addition, our reach extends throughout our extensive network for care delivery. Our cutaneous oncology program is comprised of extensive dedicated disease teams that drive translational research at COH National Cancer Institute with many open trials.

Education, Licensure and Certifications

§ M.D. ,D.O. or equivalent from an accredited educational institution and boarded in respective specialty in Medical Oncology, Surgery or Dermatology.

§ Possession of, or eligibility for, unrestricted medical license in the State of California

§ Visa sponsorship available

Salary Range: $400K - $650K. The range listed is exclusively for base compensation for full-time employment and does not include incentive compensation or benefits. Actual compensation will be adjusted for experience, training, hospital/community need and other factors.

About City of Hope

City of Hope is an independent biomedical research and treatment center for cancer, diabetes and other life-threatening diseases. Founded in 1913, City of Hope is a leader in bone marrow transplantation and immunotherapy such as CAR T cell therapy. City of Hope’s translational research and personalized treatment protocols advance care throughout the world. Human synthetic insulin, monoclonal antibodies and numerous breakthrough cancer drugs are based on technology developed at the institution.  AccessHopeTM, a wholly owned subsidiary, was launched in 2019 and is dedicated to serving employers and their health care partners by providing access to City of Hope’s exceptional cancer expertise. A National Cancer Institute-designated comprehensive cancer center and a founding member of the National Comprehensive Cancer Network, City of Hope is ranked among the nation’s “Best Hospitals” in cancer by U.S. News & World Report. Its main campus is located near Los Angeles, with additional locations throughout Southern California and in Arizona.

Recently, the organization extended its reach beyond Duarte to include clinical network sites in Los Angeles, Orange, Riverside, and San Bernardino counties, steadily moving it to number one in Southern California for inpatient market share and pushing its capacity limits. In 2018, City of Hope began a transformational journey with ambitious goals in the areas of patient care, value-based care and precision medicine, hematology malignancies, stem cell transplants, and meaningful innovations and cures. Integral to the realization of these goals is the expansion of City of Hope to the Orange County market. 

Our community includes research associates, scientists, doctors, nurses, allied health professionals, graduate students, fundraising specialists, marketing professionals, volunteers and an extensive support staff. We are united by our desire to find cures, save lives and transform the future of health. Every discovery we make and every new treatment we create gives people the chance to live longer, better and more fully.

City of Hope continues to be a pioneer of patient-centered care and remains committed to its tradition of exceptional care for patients, families and and communities. Each day, we live out our credo:

"There is no profit in curing the body, if, in the process, we destroy the soul."